Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833]

  • Topic prioritisation

Status:
Topic prioritisation
Decision:
Awaiting decision
ID number:
3833

Timeline

Key events during the development of the guidance:

Date Update
05 August 2020 Topic selection. .

For further information on how we select topics for development, please see our page about topic prioritisation